Motion Sickness Treatment MarketGlobal Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

May 2018| TMR611A| Transparency

Report Highlights

Global Motion Sickness Treatment Market: Overview

Motion sickness is a common condition characterized by a set of symptoms such as dizziness, nausea, and fatigue experienced by a person while traveling. It is caused by difference in impulses received by perceived sense of motion by visual senses and vestibular system’s sense of movement. Conflict among those senses result in motion sickness. Motion sickness is estimated to be experienced by around 50% travelers; it is most widely witnessed among children and elderly people. Various prescription and OTC drugs and products are used to treat motion sickness and provide relief from its symptoms. Anticholinergic, antihistamines, and sympathomimetic are the most commonly used medications, while traditional remedies such as herbal medicines, homeopathic medicines, and others are also available as OTC products for treatment of motion sickness.

The global motion sickness treatment market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on treatment type, route of administration, distribution channel, and region. A detailed qualitative analysis of drivers and restraints of the market has been provided in the overview section. The report provides key insights of the global motion sickness treatment market comprising global pipeline analysis, key mergers and acquisitions, OTC vs. prescription drug market assessment, and Porter’s Five Forces Analysis. Additionally, the competition landscape section comprises competitive matrix, key player’s market footprint by treatment type and region, key competitive business strategies, and company profiles with business overview to understand the competitive landscape in the market. The report also provides market attractiveness analysis by region, thereby presenting a thorough analysis of the overall competitive scenario in the global motion sickness treatment market.

Global Motion Sickness Treatment Market: Key Segments

Based on treatment type, the global motion sickness treatment market has been segmented into anticholinergic, antihistamines, and others. The report also offers overview of the global motion sickness treatment market based on oral, transdermal, and other routes of administration. The treatment type segments have been analyzed based on commercially available motion sickness treatment drug and product types, route of administration, and adoption of each treatment type. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

In terms of distribution channel, the global motion sickness treatment market has been segmented into retail pharmacies, online pharmacies, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Motion Sickness Treatment Market: Regional Outlook

Geographically, the global motion sickness treatment market has been segmented into five major regions and the key countries/sub-regions in the respective region: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the motion sickness treatment market are GlaxoSmithKline plc, Perrigo Company plc, Prestige Brands, Inc., WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals, Inc., Myungmoon Pharm Co., Ltd., Baxter International, Inc. and Reliefband Technologies LLC.

The global motion sickness treatment market has been segmented as follows:

Global Motion Sickness Treatment Market, by Treatment Type
Anticholinergic
Antihistamines
Others (sympathomimetic, traditional medicines, wearable relief bands, etc.)

Global Motion Sickness Treatment Market, by Route of Administration
Oral
Transdermal
Others

Global Motion Sickness Treatment Market, by Distribution Channel
Retail Pharmacies
Online Pharmacies
Others (drug stores and hospital pharmacies)

Global Motion Sickness Treatment Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

  • Table 1 : Pipeline Analysis (1/2)
  • Table 2 : Pipeline Analysis (2/2)
  • Table 3 : Key Mergers and Acquisitions Snapshot (1/2)
  • Table 4 : Key Mergers and Acquisitions Snapshot (2/2)
  • Table 5 : Global Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
  • Table 6 : Global Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
  • Table 7 : Global Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 8 : Global Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Region, 2016–2026
  • Table 9 : North America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
  • Table 10 : North America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
  • Table 11 : North America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 12 : North America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country, 2016–2026
  • Table 13 : Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
  • Table 14 : Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
  • Table 15 : Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 16 : Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 17 : Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
  • Table 18 : Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
  • Table 19 : Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 20 : Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 21 : Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
  • Table 22 : Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
  • Table 23 : Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 24 : Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country / Sub-region, 2016–2026
  • Table 25 : Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
  • Table 26 : Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
  • Table 27 : Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 28 : Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 29 : Key Players Market Footprint Analysis, by Treatment Type
  • Table 30 : Key Players Market Footprint Analysis, by Region
  • Figure 1 : Global Motion Sickness Treatment Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
  • Figure 2 : Global Motion Sickness Treatment
  • Figure 3 : Top 3 Trends
  • Figure 4 : Global Motion Sickness Treatment Market Value Share, by Region (2017)
  • Figure 5 : Global Motion Sickness Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 6 : Global Market Value Share, by Treatment Type (2017)
  • Figure 7 : Global Market Value Share, by Route of Administration (2017)
  • Figure 8 : Global Market Value Share, by Distribution Channel (2017)
  • Figure 9 : Global Market Value Share, by Region (2017)
  • Figure 10 : OTC and Prescription Drugs Comparison Snapshot (2017)
  • Figure 11 : Global Motion Sickness Treatment Market Value Share, by Treatment Type, 2017 and 2026
  • Figure 12 : Global Motion Sickness Treatment Market Attractiveness Analysis, by Treatment Type, 2018–2026
  • Figure 13 : Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anticholinergic, 2016–2026
  • Figure 14 : Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Antihistamines, 2016–2026
  • Figure 15 : Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
  • Figure 16 : Global Motion Sickness Treatment Market Value Share, by Route of Administration, 2017 and 2026
  • Figure 17 : Global Motion Sickness Treatment Market Attractiveness Analysis, by Route of Administration, 2018-2026
  • Figure 18 : Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral Drugs, 2016–2026
  • Figure 19 : Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Transdermal Drugs, 2016–2026
  • Figure 20 : Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
  • Figure 21 : Global Motion Sickness Treatment Market Value Share, by Distribution Channel, 2017 and 2026
  • Figure 22 : Global Motion Sickness Treatment Market Attractiveness, by Distribution Channel, 2018–2026
  • Figure 23 : Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2016–2026
  • Figure 24 : Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2016–2026
  • Figure 25 : Global Motion Sickness Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
  • Figure 26 : Global Motion Sickness Treatment Market Value Share, by Region, 2017 and 2026
  • Figure 27 : Global Motion Sickness Treatment Market Attractiveness Analysis, by Region, 2018–2026
  • Figure 28 : Market Snapshot, by Country
  • Figure 29 : North America Motion Sickness Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 30 : North America Motion Sickness Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2026
  • Figure 31 : North America Motion Sickness Treatment Market Attractiveness Analysis, by Treatment Type, 2018– 2026
  • Figure 32 : North America Motion Sickness Treatment Market Value Share Analysis, by Route of Administration, 2017 and 2026
  • Figure 33 : North America Motion Sickness Treatment Market Attractiveness Analysis, by Route of Administration, 2018–2026
  • Figure 34 : North America Motion Sickness Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 35 : North America Motion Sickness Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 36 : North America Motion Sickness Treatment Market Value Share Analysis, by Country, 2017 and 2026
  • Figure 37 : North America Motion Sickness Treatment Market Attractiveness Analysis, by Country, 2018–2026
  • Figure 38 : Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 39 : Europe Motion Sickness Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2026
  • Figure 40 : Europe Motion Sickness Treatment Market Attractiveness Analysis, by Treatment Type, 2018–2026
  • Figure 41 : Europe Motion Sickness Treatment Market Value Share Analysis, by Route of Administration, 2017 and 2026
  • Figure 42 : Europe Motion Sickness Treatment Market Attractiveness Analysis, by Route of Administration, 2018–2026
  • Figure 43 : Europe Motion Sickness Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 44 : Europe Motion Sickness Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 45 : Europe Motion Sickness Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 46 : Europe Motion Sickness Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
  • Figure 47 : Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 48 : Asia Pacific Motion Sickness Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2026
  • Figure 49 : Asia Pacific Motion Sickness Treatment Market Attractiveness Analysis, by Treatment Type, 2018–2026
  • Figure 50 : Asia Pacific Motion Sickness Treatment Market Value Share Analysis, by Route of Administration, 2017 and 2026
  • Figure 51 : Asia Pacific Motion Sickness Treatment Market Attractiveness Analysis, by Route of Administration, 2018–2026
  • Figure 52 : Asia Pacific Motion Sickness Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 53 : Asia Pacific Motion Sickness Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 54 : Asia Pacific Motion Sickness Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 55 : Asia Pacific Motion Sickness Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
  • Figure 56 : Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 57 : Latin America Motion Sickness Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2026
  • Figure 58 : Latin America Motion Sickness Treatment Market Attractiveness Analysis, by Treatment Type, 2018–2026
  • Figure 59 : Latin America Motion Sickness Treatment Market Value Share Analysis, by Route of Administration, 2017 and 2026
  • Figure 60 : Latin America Motion Sickness Treatment Market Attractiveness Analysis, by Route of Administration, 2018–2026
  • Figure 61 : Latin America Motion Sickness Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 62 : Latin America Motion Sickness Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 63 : Latin America Motion Sickness Treatment Market Value Share Analysis, by Country / Sub-region, 2017 and 2026
  • Figure 64 : Latin America Motion Sickness Treatment Market Attractiveness Analysis, by Country / Sub-region, 2018–2026
  • Figure 65 : Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 66 : Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2026
  • Figure 67 : Middle East & Africa Motion Sickness Treatment Market Attractiveness Analysis, by Treatment Type, 2018–2026
  • Figure 68 : Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, by Route of Administration, 2017 and 2026
  • Figure 69 : Middle East & Africa Motion Sickness Treatment Market Attractiveness Analysis, by Route of Administration, 2018–2026
  • Figure 70 : Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 71 : Middle East & Africa Motion Sickness Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 72 : Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 73 : Middle East & Africa Motion Sickness Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
  • Figure 74 : Key Competitive Strategies Snapshot

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report